FORM 5
U.S. SECURITIES AND EXCHANGE COMMISSION _____________________
WASHINGTON, D.C. 20549 | OMB APPROVAL |
ANNUAL STATEMENT OF |_____________________|
CHANGES IN BENEFICIAL OWNERSHIP |OMB NUMBER: 3235-0362|
|EXPIRES: |
| JANUARY 31, 2005 |
Filed pursuant to Section 16(a) of the |ESTIMATED AVERAGE |
Securities Exchange Act of 1934, |BURDEN HOURS |
Section 17(a) of the Public Utility |PER RESPONSE......1.0|
Holding Company Act of 1935 |_____________________|
or Section 30(h) of the Investment
Company Act of 1940
/__/ Check box if no longer subject to
Section 16. Form 4 or Form 5 obligations may
continue. See Instructions 1(b).
/__/ Form 3 Holdings Reported
/__/ Form 4 Transactions Reported
----------------------------------------------------------------------------
1. Name and Address of Reporting Person*
-------------------------------------------------------------------------
(Last) (First) (Middle)
Jonzon Halvar B.
-------------------------------------------------------------------------
(Street)
Klarabergsviadukten 70, Section E, Box 70381
-------------------------------------------------------------------------
(City) (State) (Zip)
Stockholm Sweden SE-107 24
----------------------------------------------------------------------------
2. Issuer Name and Ticker or Trading Symbol
AUTOLIV, INC. (ALV)
----------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)
----------------------------------------------------------------------------
4. Statement of Month/Year
12/02
----------------------------------------------------------------------------
5. If Amendment, Date of Original (Month/Year)
----------------------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director 10% Owner
--- ---
X Officer (give title below) Other (specify below)
--- ---
Vice President Purchasing
----------------------------------------------------------------------------
7. Individual or Joint/Group Reporting (check applicable line)
X Form Filed by One Reporting Person
---
Form Filed by More than one Reporting Person
---
============================================================================
Table I - Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
----------------------------------------------------------------------------
1. Title of Security (Instr. 3)
----------------------------------------------------------------------------
2. Transaction Date (Month/Day/Year)
----------------------------------------------------------------------------
3. Transaction Code (Instr. 8)
----------------------------------------------------------------------------
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
----------------- ----------------- ----------------
Amount (A) or (D) Price
----------------------------------------------------------------------------
5. Amount of Securities Beneficially Owned at the end of Issuer's Fiscal Year
(Instr. 3 and 4)
----------------------------------------------------------------------------
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
----------------------------------------------------------------------------
7. Nature of Indirect Beneficial Ownership (Instr. 4)
----------------------------------------------------------------------------
[TYPE ENTRIES HERE]
============================================================================
TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially
Owned (e.g., puts, calls, warrants, options, convertible
securities)
----------------------------------------------------------------------------
1. Title of Derivative Security (Instr. 3)
Options
----------------------------------------------------------------------------
2. Conversion or Exercise Price of Derivative Security
USD 19,96
----------------------------------------------------------------------------
3. Transaction Date (Month/Day/Year)
01/02/02
----------------------------------------------------------------------------
4. Transaction Code (Instr. 8)
A
----------------------------------------------------------------------------
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
10,000
------------------- ------------------
(A) (D)
----------------------------------------------------------------------------
6. Date Exercisable and Expiration Date (Month/Day/Year)
01/02/03 01/02/12
------------------- ------------------
Date Exercisable Expiration Date
----------------------------------------------------------------------------
7. Title and Amount of Underlying Securities (Instr. 3 and 4)
Common Stock 10,000
---------------------------------- --------------------------
Title Amount or Number of Shares
----------------------------------------------------------------------------
8. Price of Derivative Security (Instr. 5)
----------------------------------------------------------------------------
9. Number of Derivative Securities Beneficially Owned at End of Year
(Instr. 4)
10,710*
----------------------------------------------------------------------------
10. Ownership of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
(D)irect
----------------------------------------------------------------------------
11. Nature of Indirect Beneficial Ownership (Instr. 4)
----------------------------------------------------------------------------
[TYPE ENTRIES HERE]
----------------------------------------------------------------------------
EXPLANATION OF RESPONSES:
* 710 Options has been previously reported.
/S/ Halvar Jonzon
---------------------------------- -----------------
** SIGNATURE OF REPORTING PERSON DATE
_____________________________
* If the form is filed by more than one reporting person, see
instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
NOTE: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure
=============================================================================